Evidence map›Paper›PMID 19007340›Full record

ArticleBioTechniques2008

Improvements to bead-based oligonucleotide ligation SNP genotyping assays.

Shannon Bruse, Michael Moreau, Marco Azaro, Ray Zimmerman, Linda Brzustowicz

Abstract read
In one paragraph

Article in BioTechniques, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Single Nucleotide Polymorphisms inDiagnostics (Basel, Switzerland) · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shannon BruseDepartment of Genetics, Rutgers University, Piscataway, NJ 08854, USA. shannon.bruse@mirusbio.com
Michael Moreau
Marco Azaro
Ray Zimmerman
Linda Brzustowicz

Funding

NIMH Center Repository Supporting Stem Cell ResearchU24MH068457 · NIMH · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BRZUSTOWICZ, LINDA M, KNOWLES, JAMES A · 2003 to 2024
$213.8M
Genetic Components of Autism Spectrum DisordersR01MH070366 · NIMH · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BRZUSTOWICZ, LINDA M · 2003 to 2007
$3.6M
Molecular Genetics of Schizophrenia SusceptibilityR01MH062440 · NIMH · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BRZUSTOWICZ, LINDA M · 2001 to 2008
$3.4M
Elucidating the Role of miRNA Dysregulation in Schizophrenia and Bipolar DisorderR01MH080429 · NIMH · RUTGERS, THE STATE UNIV OF N.J. · PI BRZUSTOWICZ, LINDA M · 2007 to 2011
$3.3M
NIMH NIH HHS R01 MH062440NIMH NIH HHS R01MH062440NIMH NIH HHS R01 MH070366NIMH NIH HHS R01MH070366NIMH NIH HHS R01 MH080429NIMH NIH HHS R01MH080429NIMH NIH HHS U24 MH068457NIMH NIH HHS U24MH068457
6 · The paper itself

Abstract

We describe a bead-based, multiplexed, oligonucleotide ligation assay (OLA) performed on the Luminex flow cytometer. Differences between this method and those previously reported include the use of far fewer beads and the use of a universal oligonucleotide for signal detection. These innovations serve to significantly reduce the cost of the assay, while maintaining robustness and accuracy. Comparisons are made between the Luminex OLA and both pyrosequencing and direct sequencing. Experiments to assess conversion rates, call rates, and concordance across technical replicates are also presented.

Indexed as

MicrospheresPolymorphism, Single NucleotideAllelesBiological AssayFlow CytometryFluorescent DyesGenetic TechniquesGenome, HumanGenotypeHumansOligonucleotidesFluorescent DyesOligonucleotides

Identifiers

PMID19007340
PMCPMC3987951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.